Richardson gives a very fair account. The literature is cited comprehensively and this book is an indexed source of references. I found little that I would dispute in fact or interpretation.
But another criticism of his and Hurt's method of searching and reading the literature is that it finds the footsteps in the sand pointing our way, while in truth, at the time the source papers were written, the "way ahead" was not evident. This is a complex book that can be read on several levels. On the surface it is a book about the history of sickle cell anaemia (SCA) in Memphis, Tennessee, the "city of the blues". But it is much more than that. Wailoo tells us about Memphis' sickle cell history in the context of the disease's twentieth-century national history. That national history, and therefore the local Memphis history, is not, in Wailoo's telling of it, just a story of scientific developments and medical care for those with the disease. As the book's subtitle suggests, Wailoo shows how the changes in scientific and medical understanding of SCA were part of a larger story that includes issues of race, politics, and economics. Claiming that "conventional histories of disease tend to follow only the professional scientists and physicians who, it is assumed, played key roles in shaping the lives of the infirm" and that "the traditional narrative for sickle cell disease dwells on the search for scientific understanding" (p. 4), Wailoo wishes to look more deeply into the impact of SCA on those who suffered from it and on the group most identified with SCA-African Americans. Putting a human face on the history of SCA means, for the author, focusing on one locale. He chose Memphis because of its richness of sources, its large African-American population, its record as a city of medicine in the twentieth-century, and its connection to SCA through patients, hospitals, and a nationally recognized white medical scientist, Lemuel Diggs, whose life and long career in SCA research spanned much of the century.
Dying in the city of the blues is not narrative history, though it is roughly chronological. The book works its way through the twentieth century from SCA's discovery (to Western medicine) in Chicago in the first decade, through the development of tests for the disease, to Linus Pauling's mid-century announcement of SCA as a molecular disease, to the recent attempts to find a cure and a treatment for the pain associated with SCA. During this time SCA was transformed from an invisible disorder with little public recognition in the white or black communities to a commodified condition that served as a vehicle to obtain funding for academic medical centres, and a politicized disease that became the centre of controversy over genetic screening and black fears of genocide. Wailoo interweaves descriptions of SCA's medical milestones with descriptions and analyses of politics, race issues, economics, medical history, and society.
Sometimes the book tries to do too much and the text wanders, losing the thread of a discussion point, as, for example, when offering details about local Memphis politics. Paradoxically, Wailoo presents his information so dispassionately that even the local story in Memphis at times loses its human face. The author distances himself perhaps too much from the subject in trying to work together the many layers. Also, Memphis is not a perfect fit for telling the entire story of SCA as he wants to tell it.
He must fill in gaps that did not occur in Memphis, again occasionally losing the thread of the local history narrative. Still, Dying makes an important contribution to American social and medical history. When one finishes the book and reflects back on its contents one realizes just how rich Wailoo's approach to his subject is, how much he has covered, how skillfully he has informed, and how nicely he has used the story of SCA to tell the stories of race, politics, and health in twentieth-century American society. Recently, the American Association for the History of Medicine's committee on Education and Outreach began to reexamine strategies to increase the visibility of medical history in the undergraduate curriculum. Houghton Mifflin, with the release of Major problems in the history of American medicine and public health, has delivered a truly outstanding product that will greatly aid in meeting the Association's goal. John Harley Warner and Janet A Tighe, editors of this book, have culled a series of choice readings from the annals of United States history, drawing upon myriad aspects of both continuity and change within health care and its delivery. The editors have also led readers, by including lucid and lively essays, toward a better understanding of the range of historiographical approaches used to interpret primary documents.
